Living and coping with HIV-1 infection is a challenge for the symptomatic patient and the family because of the lethality of the infection, the chronic nature of illness episodes, disruption of normal social roles, and the potential for social discrimination. For the asymptomatic seropositive person, the long latency period translates the threat of developing AIDS into a chronic stressor commonly leading to psychological distress. For those who are not infected with HIV but who perceive themselves at risk because of their high risk behavior, the threat of AIDS may be viewed as a profound stressor. Although the importance of psychosocial research was recognized early on in the AIDS epidemic, important psychosocial issues remain, including understanding differential rates of progression to AIDS, the role of social support in physical and mental functioning and their interrelationships. The special role of the family as a source of coping or as a stressor has more recently become seen as an important component of the care process and in disease progression. This study seeks to elucidate the role of families in HIV disease progression and for HIV prevention among injection drug users (IDUs). Over the last 5 years we have recruited 2,921 IDUs screened for HIV in the ALIVE Study in Baltimore, with 703 seropositives identified. Of these, 630 positives were enrolled for follow-up; another 1524 negatives returned at least once for serologic rescreen, and 160 seroconverters have been identified and enrolled in follow-up. Return rates for the follow-up clinic have consistently exceeded 85% at each 6 month interval. In this study we will address issues of family and other sources of social support and coping, psychological distress, and HIV progression among IDUs in a 2-year longitudinal study. We will provide data on these issues which have not been collected by our group, and we will integrate this information with biological, behavioral and psychosocial factors associated with HIV illness. We will also interview family, members to determine the influence of HIV on family dynamics, composition and functioning. Multivariate analysis incorporating interaction terms for extent of immunosuppression and family support will be used to understand psychological distress, decline in physical health status, and behavior change in IDUs as a function of family and other social support, as well as coping.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA008335-02
Application #
2120799
Study Section
Special Emphasis Panel (SRCM)
Project Start
1993-07-01
Project End
1996-06-30
Budget Start
1994-07-01
Budget End
1995-06-30
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Knowlton, A R; Hua, W; Latkin, C (2005) Social support networks and medical service use among HIV-positive injection drug users: implications to intervention. AIDS Care 17:479-92
Knowlton, Amy; Hua, Wei; Latkin, Carl (2004) Social support among HIV positive injection drug users: implications to integrated intervention for HIV positives. AIDS Behav 8:357-63
Knowlton, A R; Latkin, C A; Schroeder, J R et al. (2001) Longitudinal predictors of depressive symptoms among low income injection drug users. AIDS Care 13:549-59
Schroeder, J R; Latkin, C A; Hoover, D R et al. (2001) Illicit drug use in one's social network and in one's neighborhood predicts individual heroin and cocaine use. Ann Epidemiol 11:389-94
Pilowsky, D J; Knowlton, A R; Latkin, C A et al. (2001) Children of injection drug users: impact of parental HIV status, AIDS, and depression. J Urban Health 78:327-39
Knowlton, A R; Hoover, D R; Chung, S E et al. (2001) Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug Alcohol Depend 64:55-62